Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Condition(s):Chronic Lymphocytic Leukemia (CLL); Waldenstrom Macroglobulinemia (WM)Last Updated:March 15, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic Leukemia (CLL); Waldenstrom Macroglobulinemia (WM)Last Updated:March 15, 2024Completed
Condition(s):Herpes Zoster; Allergy and Immunology; Corona Virus InfectionLast Updated:November 22, 2023Completed
Condition(s):Respiratory DisordersLast Updated:June 23, 2022Completed
Condition(s):Inflammatory Bowel DiseasesLast Updated:September 1, 2023Recruiting
Condition(s):Safety and Tolerability; Compare SHINGRIX Vaccine Response Rates; Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)Last Updated:August 4, 2023Completed
Condition(s):RZV Vaccine (Shingrix ®)Last Updated:November 8, 2023Recruiting
Condition(s):ShinglesLast Updated:March 8, 2023Recruiting
Condition(s):Kidney Transplant Recipient Response to Shingrix VaccineLast Updated:June 5, 2023Recruiting
Condition(s):Herpes ZosterLast Updated:March 15, 2024Recruiting
Condition(s):Shingles; Vaccination Behavior; Behavior, HealthLast Updated:March 27, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.